Galapagos NV
GLPG
#4875
Rank
โ‚น178.58 B
Marketcap
โ‚น2,659
Share price
0.56%
Change (1 day)
27.70%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -โ‚น46.41 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚น0.32 Billion. In 2024 the company made an earning of -โ‚น0.54 Billion, an increase over its 2023 earnings that were of -โ‚น3.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น46.41 Billion8524.83%
2024 -โ‚น0.54 Billion-82.77%
2023 -โ‚น3.13 Billion-85.59%
2022 -โ‚น21.68 Billion60.71%
2021 -โ‚น13.49 Billion-60.08%
2020 -โ‚น33.79 Billion-331.44%
2019 โ‚น14.59 B-523.76%
2018 -โ‚น3.45 Billion-72.34%
2017 -โ‚น12.46 Billion-329.59%
2016 โ‚น5.42 B-144.3%
2015 -โ‚น12.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.123 T-6,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น788.23 B-1,690.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น614.22 B-1,339.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น716.85 B-1,546.16%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น2.087 T-4,311.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.313 T-2,749.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น921.35 B-1,958.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น4.98 Billion-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น200.36 B-504.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel